Gene Query: NDUFS7

Dataset Description Geneva Score
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 115.34
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 115.34
Efficient and quantitative high-throughput tRNA sequencing 59.7
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 44.03
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 42.43
Next generation sequencing of small RNAs isolated from exosomes in human semen 33.63
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 25.93
Argonaute proteins couple chromatin silencing to alternative splicing 25.93
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 25.53
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 25.5
Genome wide miR-191 target profile determined by RIP and gene expression profiling 25.5
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 23.91
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 23.64
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 23.37
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 23.26
Transcriptome analysis of SKI knock-out in HL60 cells 23.26
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 22.62
Human cells contain natural double-stranded RNAs with potential regulatory capacity 21.46
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 19.73
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 19.54
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 19.14
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 18.52
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 18.47
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 18.1
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 18.03
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 17.95
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 17.78
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 16.93
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 16.47
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 16.06
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 15.85
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 15.82
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 15.75
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 15.68
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 15.52
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 15.52
Global analysis of enhancer targets: Mosaic-seq 14.83
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 14.66
U1 snRNP telescripting regulates size-function stratified human genome 14.66
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 14.66
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 14.49
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 14.49
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 14.32
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 14.28
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 14.19
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 13.87
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 13.82
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 13.76
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 13.66
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 13.53
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 13.48
Differentiation enhances Zika virus infection in neuronal brain cells 13.4
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 13.29
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 13.19
High-Throughput Kinetic Analysis of Fractional Killing 12.84
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 12.82
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 12.79
Role of microRNAs in the interaction between Salmonella and the host cell 12.78
Determination of tRNA aminoacylation levels by high throughput sequencing 12.46
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 12.43
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 12.19
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 12.15
Comparison of microRNA Profiling Platforms (HTS) 12.11
Comparison of microRNA Profiling Platforms 12.11
LNCaP treated with iBET 11.74
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 11.56
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 11.47
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 11.3
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 11.24
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 11.16
The comparison of high-throughput single-cell RNA-seq methods 11.13
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 11.09
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 11.07
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 11.07
Impact of dieldrin on transcription in Jurkat T cells 11.01
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 10.96
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 10.89
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 10.89
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 10.85
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 10.81
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 10.7
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 10.46
hTERT promotes cell adhesion and migration independent of telomerase activity 10.31
Ribosomal footprinting of MDA-Parental and MDA-LM2 10.3
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 10.28
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 10.23
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 10.17
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 10.09
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 10.05
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 9.91
Transcriptome of human white and brown adipose tissue biopsies 9.86
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 9.83
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 9.67
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 9.6
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 9.49
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 9.37
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 9.3
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 9.25
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 9.18
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 9.16
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 9.13
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 9.13
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 9.02
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 8.96
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 8.96
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 8.93
CROP-Seq in Primary Human T Cells 8.91
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 8.85
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 8.84
Gene expression profiling of leukemia cells following asparagine depletion 8.81
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 8.81
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 8.74
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 8.73
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 8.66
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 8.62
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 8.48
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 8.44
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 8.26
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 8.22
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 8.13
The effect of insulin on mRNA transcription of human pluripotent stem cells 8.12
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 8.05
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 8.05
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 7.99
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 7.99
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 7.98
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 7.96
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 7.95
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 7.91
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 7.9
RNA-seq of naive and primed ES cells (NHSM) 7.86
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 7.83
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 7.81
Stem and effector CD8 T-cells from human cancers 7.71
HNF1A deficiency impairs β-cell fate, granule maturation and function 7.68
Integrating single-cell transcriptomic data across different conditions, technologies, and species 7.65
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 7.64
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 7.53
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 7.45
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 7.44
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 7.43
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.39
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 7.34
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 7.34
Transcriptome sequencing of K-562 cells 7.31
RNA-seq of IL-4 stimulated human keratinocytes 7.3
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 7.26
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 7.19
Mutational landscape of splicing genes and functional consequences across 33 cancer types 7.18
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 7.18
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 7.16
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 7.15
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 7.11
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 7.07
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 7.05
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 7.04
Differential gene expression of human melanoma cells [RNA-seq] 7.04
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 6.99
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 6.99
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 6.97
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 6.96
Regulation of highly expressed hCINAP on translatome 6.88
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 6.82
Oncogenic MYC induces a dependency on the spliceosome in human cancer 6.81
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 6.8
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 6.7
Epigenomic landscape during organ formation in human early embryos 6.68
Identification of renal resident macrophages across species 6.65
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 6.65
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 6.55
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 6.53
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 6.52
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 6.52
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 6.52
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 6.46
Genome wide expression change by RNF168 knocking down in MCF-7 cells 6.41
METTL3 promotes translation in human cancer cells 6.39
RIG-I and MDA5 fRIP during KSHV lytic reactivation 6.39
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 6.36
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 6.36
RNA polymerase in pre-B-ALL cell lines 6.32
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 6.31
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 6.29
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 6.16
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 6.16
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 6.14
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 6.13
Single-nucleotide-resolution mapping of HBV promoters using CAGE 6.09
Ribosomal footprinting of CN34-Parental and CN34-LM1a 6.0
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 5.91
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.89
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.89
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.85
Ro60-knockout cells 5.81
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 5.72
RNA splicing alteration on glioblastoma and normal neural stem cells 5.71
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 5.67
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 5.67
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 5.61
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 5.6
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 5.59
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 5.59
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 5.58
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 5.58
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 5.57
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 5.57
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 5.56
RNA-sequencing of formalin fixed human primary melanoma tissue 5.51
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 5.5
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 5.48
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 5.47
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 5.46
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 5.4
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 5.4
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 5.38
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 5.31
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 5.31
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 5.3
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 5.25
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 5.24
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 5.24
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 5.22
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 5.18
Ribosomal protein RPL26 is the principal target of UFMylation 5.16
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 5.14
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 5.14
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 5.09
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 5.09
Gene expression in GBM with Cav3.2 inhibition 5.09
N6-methyladenine DNA Modification in Glioblastoma 5.07
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 5.07
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 5.07
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 5.07
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 5.06
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 5.06
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 5.04
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 5.01
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 4.96
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 4.95
Hijacking of stress response machinery by oncogenes in acute leukaemia 4.95
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 4.95
Landscape and variation of RNA secondary structure across the human transcriptome 4.95
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 4.9
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 4.86
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 4.84
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 4.84
Effect of PBK knockdown on C4-2 cell transcriptome 4.81
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 4.78
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 4.72
scRNASeq analysis of cycling cardiomyocytes 4.7
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 4.68
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 4.64
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 4.64
Iron response of HepG2 cells 4.52
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 4.43
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 4.4
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 4.36
Peptidomimetic blockade of MYB in acute myeloid leukemia 4.31
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 4.31
High-throughput sequencing of PROMPT-enriched samples. 4.27
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 4.27
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 4.26
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 4.26
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 4.25
Comparative Analysis of Cas9 Activators Across Multiple Species 4.23
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 4.22
Gene expression signatures of innate lymphoid cells from human blood 4.2
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 4.2
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 4.18
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 4.11
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 4.03
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 4.01
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 4.0
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 3.99
PRDM1 inhibits proliferation of human colon cancer organoids 3.96
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 3.86
ARID1A regulates condensin II distribution and chromosomal partition 3.86
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.84
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 3.82
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 3.82
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 3.74
Differential gene expression profiles in imatinib-resistant cell lines 3.72
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 3.67
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.67
RNA-Seq of PRMT1 overexpression ECA109 cells 3.64
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 3.63
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 3.63
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 3.6
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 3.57
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 3.56
Illumina Total RNA-seq in HeLa 3.54
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 3.48
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.48
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.46
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.46
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 3.39
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 3.33
EWSR1 influences alternative splicing through direct and indirect mechanisms 3.33
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.32
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 3.29
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 3.29
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 3.29
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 3.29
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 3.28
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 3.27
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 3.27
Nutritional control of protein translation 3.26
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 3.24
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 3.24
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 3.24
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 3.21
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 3.19
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 3.18
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 3.17
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 3.07
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 3.07
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 3.05
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 2.97
Microprocessor mediates transcription termination in long noncoding microRNA genes 2.96
Aneuploidy-induced cellular stresses limit autophagic degradation. 2.93
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 2.91
Tracing Enhancer Networks using Epigenetic Traits (TENET) 2.89
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 2.88
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 2.87
Myc activation coordinates gene transcription and protein translation responses 2.79
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.77
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 2.76
Functional role of CPPED1 in trophoblasts. 2.75
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 2.73
Analysis of transcriptional regulation by Myt1 and Myt1l 2.7
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 2.69
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 2.69
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 2.68
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 2.68
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 2.65
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 2.65
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 2.63
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 2.63
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.61
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 2.6
AUF-1 affected genes in human skin cells 2.55
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 2.55
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.53
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.52
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 2.5
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 2.48
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 2.46
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 2.45
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 2.45
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.44
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.44
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.4
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 2.39
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 2.39
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 2.37
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 2.35
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 2.35
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 2.28
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.2
Copper Regulation of HIF-1 Transcription Activity 2.19
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.19
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 2.19
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 2.17
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 2.17
RNA-seq analysis upon ARID1B overexpression 2.16
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.11
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 2.1
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.08
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 2.03
Ribosome profiling upon inhibition of eIF4A 2.03
Functional significance of the HIV-1 Tat signature amino acid residues 2.02
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 2.0
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 1.98
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 1.98
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.98
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 1.97
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 1.95
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.91
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.91
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.91
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 1.87
The transcriptome effect of overexpressing EZH2 in MCF7 1.86
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.85
Genome-wide mapping of TEL-AML1 targets in acute leukemia 1.84
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.8
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.8
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 1.7
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 1.66
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 1.66
Regulatory network controlling tumor-promoting inflammation in human cancers 1.66
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.59
Expression charcaterization of an internal protocol developed to differentiate RPE cells 1.58
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.58
Induced DNA demethylation, genome instability and transcription 1.58
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 1.58
A transcriptome dataset revealing the molecular features of breast cancer stem cells 1.57
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 1.54
Genome-wide Analysis of Chromatin Interactions in Human Cells 1.54
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 1.54
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.52
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 1.51
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 1.48
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.45
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.45
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.44
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 1.43
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 1.43
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.41
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.41
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 1.41
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.4
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.39
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.39
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.38
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 1.38
Trascriptome of thyroid cancer-induced macrophages 1.37
Single-cell analysis of human kidney organoids 1.33
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.32
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 1.29
RNA editing in nascent RNA affects pre-mRNA splicing 1.24
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 1.21
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.2
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.2
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 1.2
Trans-differentiation of human adult peripheral blood T cells into neurons 1.2
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 1.17
RNA expression profiles comparing primary and omental ovarian carcinoma samples 1.16
RNA seq with AML (NB4) cells upon FTO inhibition 1.15
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.14
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.14
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 1.13
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 1.13
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.1
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 1.04
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.98
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.98
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.97
miRNAs affected by antagomiR-17 treatment 0.94
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 0.92
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.91
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.88
Transcriptomes in healthy and CHB fetal hearts 0.88
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 0.85
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 0.85
mRNA differential expression analysis in a human ex vivo model of chronic wounds 0.84
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.83
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.81
ARS2 is a general suppressor of pervasive transcription [RNAseq] 0.79
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 0.77
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 0.72
Transcriptome-wide modulation of splicing by the exon junction complex 0.7
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.7
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.68
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.68
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.66
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.6
Gene expression profiling of papillary thyroid cancer from central and invasive regions 0.54
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.52
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.5
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.5
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 0.45
BACH2 in human plasma cell fate decision 0.44
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.4
Effect of FGF13 depletion on the H460 cell line 0.38
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 0.36
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.34
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.34
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.34
K562 polyA RNA-Seq 0.34
Unique features and clinical importance of acute alloreactive immune responses 0.34
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.33
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.31
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.28
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.28
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.28
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.27
Identification of a LIF-responsive replication-competent human β cell 0.23
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.22
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.22
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.22
iPSC derived motor neuron cultures from C9ORF72 carriers 0.21
The role of m6A/m-RNA methylation in stress response regulation 0.18
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.18
SRSF1 role in cellular gene expression and splicing 0.16
The circadian transcriptional landscape in primary human mammary epithelial cells 0.16
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 0.15
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 0.15
Transcriptomic analysis of human macrophages in 3D 0.14
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.12
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.12
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.11
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 0.1
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.09
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.06
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 0.05
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.05
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.05
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.05
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.03
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation